Herbal formula plus standard care for anti-synthetase syndrome lung disease
Part of Lungs & breathing clinical trials.
This trial tests whether adding a traditional Chinese herbal formula to standard treatment helps people with anti-synthetase syndrome-related interstitial lung disease. It may reduce symptoms and improve lung function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with anti-synthetase syndrome and have lung disease confirmed by a CT scan.
- You are currently taking at least 30 mg of prednisone (or an equivalent steroid) daily.
- You have not had a stem cell transplant in the last 3 months.
- You have not taken other herbal remedies in the last 2 weeks.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tetrandrine tablets can help people with lung disease caused by connective tissue disorders. It is for adults 18-80 who have stable treatment and meet specific health criteria.
This trial is testing a traditional Chinese herbal formula to see if it helps people with advanced liver cancer who are about to get a second or third treatment. It may work better than standard care alone for those with a 'damp-heat' syndrome, which is a traditional Chinese medicine way of describing certain symptoms.
This study combines traditional Chinese medicine with Western medicine to treat rheumatoid arthritis. It aims to see how well this approach works for people with hard-to-treat RA or RA-related lung disease.
This trial combines traditional Chinese herbal medicine with standard Western treatments for people with rheumatoid arthritis that hasn't responded well to at least two prior medications. It aims to see if the combination is more effective and safe.
This study tests whether adding a traditional Chinese medicine called Zhen-Qi-Jie-Du granules to usual palliative care can improve outcomes for people with advanced colorectal cancer. It aims to see if the combination offers extra benefits without causing more harm.
This trial tests a Chinese herbal medicine called Qifangfeixian granules for people with lung scarring (interstitial lung disease) related to connective tissue diseases (like lupus or scleroderma). It compares the medicine to a placebo to see if it helps improve breathing and lung function.
Hear when a new Anti-Synthetase Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.